Literature DB >> 7557426

Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain).

M Kapoor1, L Zhang, P M Mohan, R Padmanabhan.   

Abstract

Dengue virus type 2 (DEN-2), a member of the Flaviviridae family, has a positive-strand RNA genome, 10,723 nucleotides (nt) in length and encoding a single polyprotein precursor consisting of 3391 amino acids (aa). In order to construct a full-length cDNA clone, the viral genome was cloned into 5' (nt 1-2203 under the control of the T7 promoter (pT7)) and 3' (nt 2203-10,723) constructs. A full-length DEN-2 cDNA under pT7 control was assembled in vitro after excising the two cDNA inserts from the 5' and 3' constructs, and joining them with T4 DNA ligase. The RNA produced by in vitro transcription of the cDNA using T7 RNA polymerase was infectious, as shown by transfection of permissive BHK-21 and Vero cells, and propagation of the virus particles released into the culture media. The virus particles stably maintained the conservative mutation introduced into the 5' construct, and the cells infected with the infectious RNA-derived virus synthesized virus-specific DEN-2 antigens, as shown by immunofluorescence and immunoprecipitations. The full-length infectious clone for DEN-2 should be useful for the study of molecular mechanisms involved in viral RNA replication and virus assembly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557426     DOI: 10.1016/0378-1119(95)00332-z

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  25 in total

1.  Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.

Authors:  B Puri; S Polo; C G Hayes; B Falgout
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

3.  Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus.

Authors:  Wolfgang Fischl; Sigrid Elshuber; Sabrina Schrauf; Christian W Mandl
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast.

Authors:  S Polo; G Ketner; R Levis; B Falgout
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes.

Authors:  Szu-Yuan Pu; Ren-Huang Wu; Chi-Chen Yang; Tzu-Ming Jao; Ming-Han Tsai; Jing-Chyi Wang; Hui-Mei Lin; Yu-Sheng Chao; Andrew Yueh
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

6.  Rescue and Characterization of Recombinant Virus from a New World Zika Virus Infectious Clone.

Authors:  James Weger-Lucarelli; Nisha K Duggal; Aaron C Brault; Brian J Geiss; Gregory D Ebel
Journal:  J Vis Exp       Date:  2017-06-07       Impact factor: 1.355

7.  Infectious cDNA clone of the epidemic west nile virus from New York City.

Authors:  Pei-Yong Shi; Mark Tilgner; Michael K Lo; Kim A Kent; Kristen A Bernard
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA.

Authors:  N Ruggli; J D Tratschin; C Mittelholzer; M A Hofmann
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini.

Authors:  A Aiyar; P Hindmarsh; A M Skalka; J Leis
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines.

Authors:  Mariel E Pérez-Vélez; Teresita García-Nieves; Candimar Colón-Sánchez; Idalí Martínez
Journal:  P R Health Sci J       Date:  2009-09       Impact factor: 0.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.